Phase 1 First-line Treatment Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer

First-line TreatmentMetastatic Colorectal Cancer (CRC)Phase 1+4 more

M.D. Anderson Cancer Center41 enrolled1 locationNCT07500298

Recruiting

Phase 1

Paclitaxel Cationic Liposome (Hepatic Arterial Infusion) in Combination With Systemic Therapy as First-Line Treatment in Colorectal Liver Metastases

First-line TreatmentColorectal Liver Metastases

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.7 enrolled1 locationNCT07117435

Recruiting

Phase 1Phase 2

A Study of AK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell Carcinoma

Renal Cell CarcinomaFirst-line Treatment

Hao Zeng33 enrolled1 locationNCT05808608